Skip to main content

Follow us

Home

Search

the Gateway to Research in Oklahoma

  • Researchers
  • Providers
  • Patients
  • About GRO

Gateway to Research in Oklahoma


Oklahoma Shared Clinical and Translational Resources U54 GM104938

Researchers

imgResearchers

The GRO: Researcher Portal provides resources, information, and training to help individuals or communities involved in performing clinical and translational research in Oklahoma.

Providers

imgProviders

The GRO: Provider Portal assists medical providers to identify clinical research opportunities in Oklahoma, tools for patient education, and evidence-based resources to improve patient care.

Patients

imgPatients

The GRO: Patient Portal can help patients and families to learn more about clinical and translational research and to connect with opportunities to participate in research opportunities in your communities.

Oklahoma Research Highlights

Mapping global avian influenza risk patterns through waterbird activity entropy

3 months 1 week ago
Avian influenza viruses (AIV) pose a major zoonotic threat with pandemic potential. Waterbirds facilitate AIV spillovers into farm animals and humans through exposure and virus reassortment. Here, we propose waterbird activity entropy (WAE), an indicator of waterbird activity intensity based on monthly distributions of 779 species worldwide. WAE demonstrated high explanative power (AUC = 0.87 ± 0.001) for global avian influenza cases, particularly for H5N1, revealing the potential of WAE for...
Yuzhe Li

Methamphetamine-associated PAH on the Rise in the US: Geographic Trends & Disparities in Patient Demographics and Treatment Strategies

3 months 1 week ago
CONCLUSIONS: This study highlights distinct characteristics of the growing Meth-APAH population, emphasizing the necessity for greater national awareness. Critical measures include improved routine screening, tailored pharmacologic and addiction treatments, longitudinal psychosocial support, and adequate documentation of methamphetamine use within healthcare claims to effectively address the unmet needs in this population.
Nick H Kim

Surfactants promote the transport of hydrophilic compounds through hydrophobic nanopores in leaves: mechanistic insights

3 months 1 week ago
No abstract
Takeshi Kobayashi

MHC-I upregulation and increased glucose dependence define innate antifungal immune responses to Cryptococcus neoformans

3 months 1 week ago
CONCLUSION: These findings indicate that metabolic reprogramming is critical for effective antifungal responses. Our data provide a foundation for future studies aimed at targeting host immune and metabolic pathways to enhance antifungal immunity.
Ayesha S Nair

A Comparative Effectiveness Study of Lorazepam or IVIg Versus no Treatment for Down Syndrome Regression Disorder

3 months 1 week ago
CONCLUSIONS: At the endpoint of 24 weeks, both IVIg and lorazepam were superior to no treatment for DSRD but IVIg was superior to lorazepam for all five outcomes. Between 12 and 24 weeks of treatment, IVIg showed greater improvement in all outcomes than did lorazepam, suggesting that at least a 24-week treatment course is necessary for maximum IVIg benefit.
Jonathan D Santoro

Pagination

  • Previous page ‹ Previous
  • Page 18
  • Next page Next ›
Subscribe to

octsi logo

1000 N. Lincoln Blvd, Suite 2100, Oklahoma City, OK 73104
Copyright © 2021 The Board of Regents of the University of Oklahoma, All Rights Reserved.

About GRO

News
Publications
FAQ

Terms of Use

Privacy Policy
Accessibility

Contact

info email
info phone
Copyright © 2026. All rights reserved. Designed By Zymphonies